The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756
Related Posts
Fang D, McWIlliams J, Wang C, Maziero D, Iwamoto KS, Kishan AU, Finn JP, Zhong X, Ruan D. In-Depth optimization and characterization of prostatic and[...]
Zhang Y, Siu KL, Huang K, Huang Y, Cai H. Attenuation of advanced atherosclerosis and aortic aneurysm in hph-1/apoE DKO mice by folic acid and[...]
Miyazaki K, Olivas JA, Miyazaki Y, Sato T, Rimmer M, Moussa ID, Fishbein MC, Shivkumar K, Mori S. Impinged and Disrupted Left Bundle Branch by[...]